Cellular Effect
| Cell Line | Activity | Value | Description | Reference |
|---|---|---|---|---|
| BXPC-3 | IC50 | 1.22 μM | Antiproliferative activity against human BXPC-3 cells assessed as inhibition of cell growth incubated for 72 hrs by MTT assay | [PMID: 36202064] |
| CT26 | IC50 | 48.26 μM | Antiproliferative activity against human CT26 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay | [PMID: 33862375] |
| GES1 | IC50 | 4.31 nM | Cytotoxicity against human GES1 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay | [PMID: 36599264] |
| HCT-116 | IC50 | 0.55 μM | Antiproliferation activity against human HCT116 cells assessed as reduction in cell viability incubated for 48 hrs by MTT assay | [PMID: 33214826] |
| HepG2 | IC50 | 4.29 nM | Antiproliferative activity against human HepG2 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay | [PMID: 36599264] |
| HL-60 | IC50 | 0.09 μM | Antiproliferative activity against BRD4-sensitive human HL60 cells after 72 hrs by CCK8 assay | [PMID: 28314513] |
| HL-60 | IC50 | 0.12 μM | Antiproliferative activity against human HL60 cells assessed as reduction in cell viability by MTT assay | [PMID: 31857846] |
| HT-29 | IC50 | 1.84 nM | Antiproliferative activity against human HT-29 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay | [PMID: 36599264] |
| K562 | IC50 | > 10 μM | Antiproliferative activity against BRD4-independent human K562 cells after 72 hrs by CCK8 assay | [PMID: 28314513] |
| Kasumi 1 | IC50 | 6.3 nM | Antiproliferative activity against human Kasumi-1 cells assessed as reduction in cell viability measured after 72 hrs by Celltitre-glo luminescence assay | [PMID: 32208600] |
| MCF7 | IC50 | 12.27 nM | Antiproliferative activity against human MCF7 cells assessed as reduction in cell viability incubated for 72 hrs by MTT assay | [PMID: 36599264] |
| MM1.S | IC50 | 6.5 nM | Antiproliferative activity against human MM1S cells assessed as reduction in cell viability measured after 72 hrs by Celltitre-glo luminescence assay | [PMID: 32208600] |
| MV4-11 | IC50 | 0.07 μM | Antiproliferative activity against BRD4-sensitive human MV411 cells after 72 hrs by CCK8 assay | [PMID: 28314513] |
| MV4-11 | IC50 | 1.9 nM | Antiproliferative activity against human MV4-11 cells assessed as reduction in cell viability measured after 72 hrs by Celltitre-glo luminescence assay | [PMID: 32208600] |
| MX1 | EC50 | 13 nM | Antiproliferative activity against human MX1 cells after 72 hrs by Cell Titer Glo assay | [PMID: 28949521] |
| MX1 | EC50 | 13 nM | Antiproliferative activity against human MX1 cells incubated for 72 hrs by cell-titer Glo assay | [PMID: 29678460] |
| RS4-11 | IC50 | 6.4 nM | Antiproliferative activity against human RS4:11 cells assessed as reduction in cell viability measured after 72 hrs by Celltitre-glo luminescence assay | [PMID: 32208600] |
| U-266 | IC50 | 2.03 μM | Antiproliferative activity against human U-266 cells assessed as inhibition of cell proliferation incubated for 48 hrs by MTT assay | [PMID: 33862375] |
18 records · Scroll to view more